Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section

A Phase 1, Single Dose Pk And Safety Study With Ni-03 Followed By A Phase 2, Randomized, Double-Blind, Parallel-Group Dose-Ranging Study To Evaluate The Safety And Efficacy Of Ni-03 Compared To Placebo In Subjects With Chronic Pancreatitis

Principal Investigator

Timothy Gardner

Study Number

F16024

Summary

The purpose of this study is to determine the safety and efficacy of NI-03.

Phase

Phase I/II

Contact

Anna Haron

Available at the following location(s)

  • Lebanon

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms

0